Clinical measures in transthyretin familial amyloid polyneuropathy

被引：53
|
作者：
Coelho, Teresa [1 ]
Vinik, Aaron [2 ]
Vinik, Etta J. [2 ]
Tripp, Tara [3 ]
Packman, Jeff [4 ]
Grogan, Donna R. [4 ]
机构：
[1] Hosp Santo Antonio, Ctr Hosp Porto, P-4099001 Oporto, Portugal
[2] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Norfolk, VA 23501 USA
[3] DM Stat Inc, Malden, MA USA
[4] FoldRx Pharmaceut Inc, Cambridge, MA USA
来源：
MUSCLE & NERVE | 2017年 / 55卷 / 03期
关键词：
amyloidosis; modified body mass index; nerve fiber function; Neuropathy Impairment Score; Norfolk Quality of Life; ROCHESTER DIABETIC-NEUROPATHY; RETINOL-BINDING-PROTEIN; LIVER-TRANSPLANTATION; FOLLOW-UP; PERIPHERAL NEUROPATHY; END-POINTS; TAFAMIDIS; SURVIVAL; TRIAL; DYSFUNCTION;
D O I：
10.1002/mus.25257
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IntroductionThis observational, cross-sectional, single-center study aimed to identify instruments capable of measuring disease progression in transthyretin familial amyloid polyneuropathy (TTR-FAP). MethodsThe relationship between disease stage and Neuropathy Impairment Score-Lower Limbs (NIS-LL) and Norfolk Quality of Life-Diabetic Neuropathy (Norfolk QOL-DN) total score was assessed in 61 (stages 1-3) patients with TTR-FAP (V30M variant) and 16 healthy controls. Composite measures of large- and small-nerve fiber function, and modified body mass index (mBMI) were also assessed. ResultsOrdinal-based NIS-LL and Norfolk QOL-DN scores discriminated between disease stages (P<0.0001 for NIS-LL and Norfolk QOL-DN). Longer disease duration correlated with worse NIS-LL and Norfolk QOL-DN. Karnofsky performance score declined progressively by disease stage. Composite measures of nerve fiber function differentiated stage 1 from stage 2 disease. The mBMI declined with advancing disease. ConclusionsNIS-LL, Norfolk QOL-DN score, composite endpoints of nerve fiber function, and mBMI are valid, reliable measures of TTR-FAP severity. Muscle Nerve55: 323-332, 2017
引用
收藏
页码：323 / 332
页数：10
相关论文
共 50 条
  • [31] Evolution of amyloid fibrils in transthyretin familial amyloid polyneuropathy: An ultrastructural study
    Koike, Haruki
    Nishi, Ryoji
    Ikeda, Shohei
    Kawagashira, Yuichi
    Iijima, Masahiro
    Katsuno, Masahisa
    Sobue, Gen
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 321 - 321
  • [32] Clinical features of familial amyloid polyneuropathy carrying transthyretin mutations in four Chinese kindreds
    Liu, Gonglu
    Ni, Wang
    Wang, Hongxia
    Li, Hongfu
    Zhang, Yue
    Wang, Ning
    Wu, Zhiying
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (01) : 19 - 26
  • [33] CLINICAL CHARACTERISTICS AND HEALTH STATE UTILITIES IN PATIENTS WITH TRANSTHYRETIN FAMILIAL AMYLOID POLYNEUROPATHY IN BRAZIL
    Stewart, M.
    Mundayat, R.
    Alvir, J.
    Grima, D.
    Tran, D.
    Ong, M.
    Rill, D.
    VALUE IN HEALTH, 2017, 20 (05) : A223 - A223
  • [34] TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY IN POLAND-GENOTYPIC AND CLINICAL PRESENTATION
    Lipowska, M.
    Drac, H.
    Rowczenio, D.
    Gilbertson, J.
    Philip, N.
    Hawkins, P. N.
    Ptasinska-Perkowska, A.
    Lasek-Ball, A.
    Brydak-Godowska, J.
    Chandoga, J.
    Kostera-Pruszczyk, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 332 - 333
  • [35] Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study
    Ines, Monica
    Coelho, Teresa
    Conceicao, Isabel
    Duarte-Ramos, Filipa
    de Carvalho, Mamede
    Costa, Joao
    NEUROEPIDEMIOLOGY, 2018, 51 (3-4) : 177 - 182
  • [36] Recommendations regarding diagnosis and treatment of transthyretin familial amyloid polyneuropathy
    Garcia-Pavia, Pablo
    Munoz-Beamud, Francisco
    Casasnovas, Carlos
    MEDICINA CLINICA, 2015, 145 (05): : 211 - 217
  • [37] Liver transplantation in transthyretin-related familial amyloid polyneuropathy
    Stangou, AJ
    Hawkins, PN
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (05) : 615 - 620
  • [38] Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy
    Kerschen, Philippe
    Plante-Bordeneuve, Violaine
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2016, 18 (12)
  • [39] Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy
    Schmidt, Hartmut H-J.
    Barroso, Fabio
    Gonzalez-Duarte, Alejandra
    Conceicao, Isabel
    Obici, Laura
    Keohane, Denis
    Amass, Leslie
    MUSCLE & NERVE, 2016, 54 (03) : 353 - 360
  • [40] Ocular manifestations of transthyretin-related familial amyloid polyneuropathy
    Antoine Rousseau
    Emmanuel Barreau
    Julia Meney
    Zoia Mincheva
    Cécile Cauquil
    Marie Théaudin
    Marc Labetoulle
    David Adams
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
12345